Magdalena Stankiewicz
The Maria Sklodowska-Curie National Research Institute of Oncology
Papers
2
Total Citations
18
H-Index
2
About
Magdalena Stankiewicz is a clinical researcher specializing in the application of robotic stereotactic radiosurgery for the treatment of brain metastases. Her work focuses on improving prognostic accuracy and treatment personalization for patients with cerebral tumors. Stankiewicz’s major contributions include the development of a novel prognostic score that predicts survival in patients undergoing robotic stereotactic radiosurgery, a tool designed to be used without requiring a full diagnostic workup, thereby streamlining clinical decision-making. Her research has also explored the interplay between clinical factors and volumetric dosimetry, revealing that active systemic disease may significantly influence local tumor control in the brain. While her most-cited paper has garnered 15 citations, her work is foundational in refining radiosurgical protocols. Stankiewicz’s studies, such as her 2020 analysis of clinical and volumetric predictors, underscore her commitment to integrating biological and physical dose considerations into treatment planning. Her achievements provide valuable insights for oncologists and radiation therapists seeking to optimize outcomes for patients with metastatic brain disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2